PKHD1L1 and melanoma: The results also showed that PKHD1L1 expression was positively associated with patient survival in the melanoma dataset GSE19234 (OS, hazard ratio (HR) = 0.62 (0.39–0.98), p = 0.042304) and lung cancer dataset GSE8894 (relapse-free survival (RFS), HR = 0.46 (0.22–0.94), p = 0.034149) (Figure 2B).